29th January – 1st February 2018 | Paris, France


about-blue guide-dark register-blue
agenda-dark speakers-blue partners-red

Welcome to the 2nd Microbiome Drug Development Summit Europe 2018

The profound impact that microbial communities have on human health is providing new therapeutic and diagnostic modalities to effectively treat disease. As a result of this excitement, the human microbiome has become a gold mine of opportunity for emerging biotech, established pharmaceutical companies, investors and researchers.

Part of the global “Microbiome Movement Series” the Microbiome Drug Development Summit will be the foremost event for industry leaders to help accelerate the precise translation of microbiome R&D from disease causation into safe, effective and commercially scalable therapeutics.

Download the full programme here to see how leading researchers are addressing unique scientific and product developmental challenges when bringing about a new age of microbiome-based therapeutics.

Download the Full Event Guide

TN shadow

What are Microbiome Drug Development Speakers looking forward to:

9226 - Microbiome Drug Development Summit Europe - Speaker Highlights

Microbiome Drug Development Summit, Boston, June 2017: Your Highlights



DNAgenotek_logo_RGB Quay Pharma Campture logo
ProDigest luina
Cosmos ID  zrc_hi-res_logo



NIZO - large


Part of the Microbiome Movement Series

MN  gb